Sublicensee Identification: The parties intend that MPP will identify potential manufacturers of pharmaceutical products with a view to enter into Sublicenses. Upon identification of such a manufacturer, in each case, MPP shall provide notice to AbbVie of the identity of the manufacturer and basic information.
Sublicensee Certification: MPP shall only enter into Sublicenses with entities
that have produced reasonable evidence demonstrating their intent and capability to:
(a) comply with applicable laws relating to corruption; and
(b) manufacture Licensed Products in compliance with the obligations set forth in the Sublicense.
MPP shall not enter into a Sublicense with a party without AbbVie’s prior written consent with respect to that party.